Hosted on MSN
Praxis Precision’s tremor-drug trial succeeds where others have failed. The stock is skyrocketing.
Shares of biopharmaceutical company Praxis Precision Medicines Inc. soared Thursday, boosted by the successful trial of a new drug to treat movement disorders. The drug, ulixacaltamide, targets ...
Shares of Novo Nordisk slumped to their lowest level since July 2021 on Monday morning after the drugmaker announced that its long-shot trial testing the impact of its Ozempic on the progression of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results